New combo injection may ease stubborn hip pain
NCT ID NCT07427238
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether adding a nerve block (PENG block) to a standard steroid injection into the hip joint can better relieve pain from hip osteoarthritis. Researchers followed 50 patients whose pain persisted despite other treatments. The goal was to see if the combination provides more effective and longer-lasting pain relief.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dexamethasone and bupivacaine injection with or without a pericapsular nerve group (PENG) block
- What this could lead to
- If successful, this approach could offer better pain relief for people with hip osteoarthritis who haven't responded to standard treatments.
- What could go wrong
- This is a small, completed observational study with only 50 participants. Results may not apply to everyone, and the nerve block adds an extra procedure with its own risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
50 people
The number who actually took part.
- Started
-
Feb 2025
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with hip pain lasting longer than 6 months due to hip osteoarthritis that has not improved with conservative methods and who have therefore undergone ultrasound-guided intra-articular steroid + local anesthetic injection and/or PENG block.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with hip pain due to hip osteoarthritis who have undergone hip intra-articular steroid + local anesthetic injection and/or PENG block under ultrasound guidance for this reason * Persistence of pain for more than 6 months * Failure of pain treatment with conservative methods Exclusion Criteria: * Those with inflammatory rheumatic joint disease (rheumatoid arthritis, gout, pseudogout, metabolic joint diseases), * History of major trauma, hip surgery * Cognitive dysfunction, history of psychiatric illness * Hepatic or renal insufficiency * Local or systemic infection * Coagulopathy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hip pain chronic are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ezgi Can
Ankara, 06010, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which anesthesia gets joint replacement patients moving sooner?
- Can a cementless hip stem hold up in asian patients?
- Physical therapy may unlock lasting activity for older adults with joint pain
- Can navigation make hip replacements more precise?
- Can sleep coaching speed recovery after joint replacement?
- Can hip replacement restore steady footing? a new study investigates